Table 2 WGS-identified LOF variants in the extended gene set

From: Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy

Family ID

Gene

Variant

ExAC variant frequency; PLi score

Notes

Segregationa

Families ”unsolved” after PS

 AJ

RYR2

c.8209_-4T>C

Absent; 1.00

Ryanodine receptor 2, SR protein involved in Ca2+ homeostasis. KO mice (-/-): embryonic lethal, (+/-): adults, normal baseline EF, ↓ contraction post-TAC; cKO mice (-/-): adults, transient ↓ contraction. CPVT families with exon 3 deletion: DCM in a subset of individuals

1/1 affected

0/1 unaffected

 AT

MYO18B

c.1692+1_1692+29del

Absent; 0

Myosin 18B, Z-disc protein. KO mice (-/-): embryonic lethal, disordered myofibrils

1/2 affected

0/3 unaffected

 BF

BDKRB1

p.R282*

0.002883; 0.07

Bradykinin receptor B1. KO mice (-/-): adults, mild ventricular dilation, normal EF

2/3 affected

2/10 unaffected

 BG

TTN b

c.31763-1G>A

0.0002733; 0

Titin, sarcomeric protein. Titin-truncating transgenic mice (-/-): embryonic lethal, (+/-): adults, stress-induced DCM. Zebrafish (+/-): adults, spontaneous DCM

3/7 affected

0/4 unaffected

 BP

RYR2

c.14757-7_14757-6delTCinsAT

Absent; 1.00

Ryanodine receptor 2 (see above)

2/3 affected

2/5 unaffected

SCN4A

p.Y600*

Absent; 0.01

α4 subunit, voltage-gated sodium channel. KO mice (-/-): adults, no heart defects reported

1/3 affected

0/5 unaffected

MYBPHL b

p.R255*

0.001450; 0

Myosin binding protein H-like, sarcomeric protein. KO mice (-/-, +/-): adults, DCM; p.R255* variant: altered MyBP-HL localization in transfected neonatal mouse cardiomyocytes

1/3 affected,

2/5 unaffected

 DF

FLNC

p.C2369*

Absent; 1.00

Filamin C, actin crosslinking protein in Z-disc and sarcolemma. KO mice (-/-): neonatal death; zebrafish MO: cardiac developmental defects

2/2 affected

2/3 unaffected

Families with identified pathogenic/likely pathogenic variants

 AM

ADRA1A

RRHQA341-345*

Absent; 0

α1A adrenoceptor. KO mice (-/-): adults, normal EF

3/3 affected

3/12 unaffected

PLEC

p.Q2360*

0.0002591; 0.02

Plectin, cytoskeletal protein. KO mice (-/-): neonatal death, Z-disc disorganization

2/3 affected

8/12 unaffected

 BK

TRIM63

p.Q247*

0.000486; 0

Tripartite motif containing 63, E3 ubiquitin ligase

p.Q247* variant: transfected cells, ↓autoubiquitination; transgenic mice, adults, ↑ LV mass, ↑ LVEDD, normal EF

2/2 affected

0/1 unaffected

 BR

TLL2

p.V441*

Absent; 0

Tolloid like 2, zinc-dependent metalloprotease. KO mice (-/-): adults, no heart defects reported

1/2 affected

1/9 unaffected

 CS

ANO5

p.N64fs

0.001027; 0

Anoctamin 5, transmembrane protein. KO mice (-/-): adults, normal EF (baseline, isoproterenol stress)

6/6 affected

0/6 unaffected.

 CZ

PDE4DIP

p.C18*

0.0000698; NA

Phosphodiesterase 4D interacting protein, A-kinase anchoring protein, contributes to phosphorylation of cMyBPC and cTNI

4/4 affected

0/2 unaffected

 DO

SYNE2

p.A6022A*

Absent; 0

Spectrin repeat-containing nuclear envelope protein 2, nuclear membrane protein. KO mice (-/-): adults, normal EF

2/3 affected

1/2 unaffected

 EA

ASB15

p.G403*

0.0000906; 0

Ankyrin repeat and SOCS box containing 15, involved in muscle differentiation and protein turnover

2/3 affected

1/3 unaffected

 MO

ACADVL

c.1077_+1G>T

Absent; 0

Very long chain acyl-CoA dehydrogenase

c.1077_+1G>T variant: 36% residual enzyme activity (predicted to be asymptomatic)

2/2 affected

0/1 unaffected

MYOM2

p.Q18*

0.0006355; 0

Myomesin 2, sarcomeric protein. Neonatal rat cardiomyocytes (-/-): ↓ rate of contraction

1/2 affected

0/1 unaffected

 R

FLNC

c.3791_-8G>A

0.0001607; 1.00

Filamin C (see above)

1/5 affected

1/2 unaffected

  1. CPVT catecholaminergic polymorphic ventricular tachycardia, DCM dilated cardiomyopathy, EF ejection fraction, ExAC Exome Aggregation Consortium, KO knockout (cKO cardiac-specific knockout), LV left ventricular, LVDD LV end-diastolic diameter, SR sarcoplasmic reticulum, TAC transverse aortic constriction, GS genome sequencing, LOF loss of function
  2. aSegregation analysis did not include phenotype-negative variant carriers aged less than 40 years
  3. bVariant absent from proband, identified by GS of additional family members